Brief: Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue
03/08/2026 14:17
BRIEF-Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue Aug 3 (Reuters) - Autolus Therapeutics PLC 6A3Ay.F:
AUTOLUS THERAPEUTICS REPORTS PRELIMINARY SECOND QUARTER 2026 NET PRODUCT REVENUE AND ANNOUNCES CREDIT FACILITY OF UP TO $250 MILLION WITH PERCEPTIVE ADVISORS
AUTOLUS THERAPEUTICS - RAISES FY 2026 SALES GUIDANCE TO $140-$150 MILLION
AUTOLUS THERAPEUTICS - REPORTS PRELIMINARY Q2 2026 AUCATZYL NET PRODUCT REVENUE OF ABOUT $45 MILLION
Source text: ID:nGNXb06YjV
Further company coverage: [6A3Ay.F]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics Reports Second Quarter 2026 Financial Results And Business Updates
Brief: Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue
Brief: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors